5 completed, 2 not yet recruiting. 5 Phase 2, 4 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Not yet recruiting 1 |
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 3 | Not yet recruiting 2, Completed 1 |
Follow Fenix Innovation Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome NTI164, Placebo - RETT Syndrome With Proven MECP2 Mutation, Rett Syndrome | Phase 2 / Phase 3 | Not yet recruiting | Fenix Innovation Group | 40 | 2027-07-01 | 2026-09-09 |
| NTI164 in Autism Spectrum Disorder NTI164, Placebo - Autism, Autism Spectrum Disorder | Phase 3 | Not yet recruiting | Fenix Innovation Group | 200 | 2026-09-30 | 2026-09-30 |
| NTI164 Human PK Study NTI164 - Healthy, Healthy Volunteer | Phase 1 | Completed | Fenix Innovation Group | 12 | 2024-02-01 | 2026-09-09 |
| Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT) NTI164 - Rett Syndrome | Phase 1 / Phase 2 | Completed | Fenix Innovation Group | 14 | 2023-09-20 | 2026-09-09 |
| Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) NTI164 - PANS Pediatric Acute-Onset Neuropsychiatric Syndrome | Phase 1 / Phase 2 | Completed | Fenix Innovation Group | 18 | 2023-06-02 | 2026-09-09 |
| Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder NTI164 - Autism Spectrum Disorder | Phase 2 / Phase 3 | Completed | Fenix Innovation Group | 54 | 2022-11-30 | 2026-09-10 |
| Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder. FEN164 - Autism Spectrum Disorder | Phase 1 / Phase 2 | Completed | Fenix Innovation Group | 18 | 2021-04-01 | 2026-09-08 |
Autism Spectrum Disorder (3) · Marijuana Abuse (3) · Rett Syndrome (2) · Autistic Disorder (1) · Pediatric acute-onset neuropsychiatric syndrome (1)
Dronabinol (1)
Australia (7)
Michael Fahey (1) · Michael Fahey, Prof (1)